Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.
about
Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide TherapyCurrent and future treatments for hepatocellular carcinomaRole of Transcatheter Intra-arterial Therapies for Hepatocellular CarcinomaTransarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsRadioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveRadioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesHepatic radiation toxicity: avoidance and ameliorationTheranostic Imaging of Yttrium-90Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheresRadioembolization and the Dynamic Role of (90)Y PET/CTHemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy.Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?Dosimetry for radiopharmaceutical therapyOptimal design of anger camera for bremsstrahlung imaging: monte carlo evaluation.Determination of Radiation Absorbed Dose to Primary Liver Tumors and Normal Liver Tissue Using Post-Radioembolization (90)Y PET.Positron emission tomography image-guided drug delivery: current status and future perspectives.Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma.Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolizationIncreased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose inhomogeneityA review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy.Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising conceptPost-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheresDose evaluation for skin and organ in hepatocellular carcinoma during angiographic procedureHigh impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization.Newer treatments for advanced hepatocellular carcinoma.Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantationDosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?Yttrium-90 radioembolization for hepatocellular carcinoma: what we know and what we need to know.The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy.Hepatic radioembolization as a bridge to liver surgery.Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors.Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.Comparison of the Adverse Event Profile of TheraSphere® with SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review.Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patientsComputational simulation of the predicted dosimetric impact of adjuvant yttrium-90 PET/CT-guided percutaneous ablation following radioembolizationClinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.Practical reconstruction protocol for quantitative (90)Y bremsstrahlung SPECT/CT.Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging.
P2860
Q26768478-F0E83754-CA4B-457A-A034-A470E0E0BC22Q26801211-3F4A9071-EAFF-4E2B-9EE0-EBDA9D6C2628Q26851627-E96F4F31-0040-4662-8275-3668F7284F01Q26852174-E0A1F210-3A77-4C3E-AC92-4582B74210D6Q26998661-3E509972-4E98-4D1A-BA51-832622224BA3Q27023616-FEB83DBA-C465-4052-B607-CD4C2670F134Q27023687-D3E36A44-EBB7-44B0-ACE2-1F1F27878ED4Q28083044-509AEBC2-4CD2-492F-A921-C640E55EB762Q28083185-D1ABD3FE-AD86-44C2-BEFA-554A5F4893A3Q30457523-5E42BDE5-4FC9-4B7F-A2DD-A1B56225C33DQ30524018-00FB03BB-C8C6-45FA-9091-C52737F79EDCQ33621522-CF16BBDA-904B-4912-952C-204B389F55CDQ33665116-9D247D51-4793-4A55-B618-784BBB010D13Q33751252-345B1B79-6D6C-41A3-B672-890029BE6FCDQ34330202-E17830AE-BB0B-4AA1-BD15-9153FB2845BCQ34446108-F0B95988-0938-47DF-9379-1F6A2D3EDEE4Q34517734-558FF5DA-DA87-44A6-9426-FB19F3483C86Q34584472-ABFDF65F-D111-4A5E-A0AF-88AC8D0209FEQ35985132-98EC6CDF-EF73-460E-BAF2-A447FA10DB5BQ36899620-D962DC61-4C5B-4288-A8A0-BC45F8E1119CQ36920698-D2FB2F99-753E-428A-A0FB-B48C01EAC773Q37071558-720ADE91-9F40-406C-B525-553C76D25B04Q37320497-A61A9026-F030-4907-8C14-3C08CA2102DDQ37565602-8EBBDB07-7BC7-4683-B2CC-82C254796CD7Q37642185-7E2CD88D-185C-49CF-B20E-D69D6F654927Q37675079-076D4AC6-EA70-4BF7-8269-8AA7F4800669Q37864161-25B5F801-6DEC-44E2-B11D-2EBB48DC1A95Q38083431-D6BE2947-E207-45DA-8EC9-78FF1FF7935CQ38219225-D1B129BD-A719-42D2-B85E-9D3E1782A099Q38240151-CF4532D8-EA82-4B04-B079-64648B3B62D9Q38241076-EE0A6354-C221-40A3-8E2E-B3726E1CAF33Q38538075-CB7F146B-197F-4B35-9419-C1DFC78039F5Q38652404-D1FDBF87-FAD7-4139-A96E-05B9DCBD3C74Q38936579-6B31750E-5CA8-4D76-9431-F67AE6880F78Q39036884-94BB5431-5473-471A-9504-A16A27E822B4Q39106320-01195877-BE42-4EAD-A3F8-61161D223EC2Q40091767-CBC16BAB-3472-467C-BC21-6931D777814EQ40586816-68AE1E2E-A728-4934-B3E0-01FF034DD369Q41511799-04B5A376-520B-481C-BCEC-D820066AA0CAQ44058512-BF55A730-7C77-41EB-B22A-2B5968D4E4B3
P2860
Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Efficacy and toxicity related ...... radiobiologic considerations.
@en
Efficacy and toxicity related ...... radiobiologic considerations.
@nl
type
label
Efficacy and toxicity related ...... radiobiologic considerations.
@en
Efficacy and toxicity related ...... radiobiologic considerations.
@nl
prefLabel
Efficacy and toxicity related ...... radiobiologic considerations.
@en
Efficacy and toxicity related ...... radiobiologic considerations.
@nl
P2093
P50
P1476
Efficacy and toxicity related ...... : radiobiologic considerations
@en
P2093
Carlo Ludovico Maini
Giuseppe Iaccarino
Giuseppe Pizzi
Livio Carpanese
Marcello Benassi
Rosa Sciuto
Sandra Rea
P304
P356
10.2967/JNUMED.110.075861
P407
P577
2010-08-18T00:00:00Z